Zero Candida Technologies Inc. Stock Analysis ZCT.V

Zero Candida Technologies, Inc. engages in the development and commercial exploitation of patents and patent applications with respect to an artificial intelligence smart tampon-like device. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2024-11-25. The firm is focused on commercial exploitation of a number of patents and patent applications with respect to an artificial intelligence (AI) smart tampon-like device, designed to treat Candidiasis and transfer the medical information through Wi-Fi to the doctor. Its technology is a combination of a therapy light source with a selected wavelength and intensity and a transparent gel-based drug delivery system to maintain the optimum Ph level in the vagina. The device, when used overnight, demonstrated 99.9999% Candidiasis elimination in the vagina within 3 nights. The device is based on smart technology that distributes light and a sensor that gathers and conveys data. The technology and the sensor itself are both patented, and together they provide focused and precise treatment, supported by scientific data. The ZC Device is designed to be re-used, such that the user only needs to clean or replace the coating before each use.